Company page
Immuneoncia Therapeutics Inc.
Immuneoncia Therapeutics Inc. is a public company traded under the ticker 424870 in the Korean market. The company has a market capitalization of approximately 244.5 million. Immuneoncia focuses on developing innovative therapies in the biotechnology sector.
- Ticker
- 424870:KRX
- Asset type
- Stock
- Market cap
- $244.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW